Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy

American Journal of Ophthalmology

Volumn 157, Issue 4, 2014, Pages 852-860

  Razavi, Sam ^a,b   Souied, Eric H ^a   Cavallero, Edoardo ^a   Weber, Michel ^c   Querques, Giuseppe ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b Transparency Eye Clinic   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE STUDY; CENTRAL SEROUS RETINOPATHY; CHOROID; CHOROID THICKNESS; CLINICAL ARTICLE; DIABETIC RETINOPATHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERVENTION STUDY; MACULAR THICKNESS; MALE; MIDDLE AGED; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DETACHMENT; RETINA FOVEA; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; CENTRAL SEROUS CHORIORETINOPATHY; CHOROID; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; IMAGING, THREE-DIMENSIONAL; INDOCYANINE GREEN; MALE; MIDDLE AGED; ORGAN SIZE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TOPOGRAPHY, MEDICAL;

EID: 84896074284     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.12.029     Document Type: Article

References (40)

1. B. Nicholson, J. Noble, F. Forooghian, and C. Meyerle Central serous chorioretinopathy: update on pathophysiology and treatment Surv Ophthalmol 58 2 2013 103 126
2. M. Gemenetzi, G. De Salvo, and A.J. Lotery Central serous chorioretinopathy: an update on pathogenesis and treatment Eye 24 12 2010 1743 1756
3. L.A. Yannuzzi Central serous chorioretinopathy: A personal perspective Am J Ophthalmol 149 3 2010 361 363
4. R. Levine, A.J. Brucker, and F. Robinson Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography Ophthalmology 96 6 1989 854 859
5. R.H. Loo, I.U. Scott, and H.W. Flynn et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy Retina 22 1 2002 19 24
6. M.S. Wang, B. Sander, and M. Larsen Retinal atrophy in idiopathic central serous chorioretinopathy Am J Ophthalmol 133 6 2002 787 793
7. R. Wong, A. Chopdar, and M. Brown Five to 15-year follow-up of resolved idiopathic central serous chorioretinopathy Eye 18 3 2004 262 268
8. C.M. Gilbert, S.L. Owens, P.D. Smith, and S.L. Fine Long-term follow-up of central serous chorioretinopathy Br J Ophthalmol 68 11 1984 815 820
9. J.M. Stewart Half dose verteporfin PDT for central serous chorioretinopathy Br J Ophthalmol 90 7 2006 805 806
10. R. Brancato, A. Scialdone, A. Pece, G. Coscas, and M. Binaghi Eight-year follow-up of central serous chorioretinopathy with and without laser treatment Graefes Arch Clin Exp Ophthalmol 225 3 1987 166 168
11. S. Otsuka, N. Ohba, and K. Nakao A long-term follow-up study of severe variant of central serous chorioretinopathy Retina 22 1 2002 25 32
12. D.M. Robertson, and D. Ilstrup Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy Am J Ophthalmol 95 4 1983 457 466
13. L. Ficker, G. Vafidis, A. While, and P. Leaver Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy Br J Ophthalmol 72 11 1988 829 834
14. T.Y. Lai, W.M. Chan, H. Li, R.Y. Lai, D.T. Liu, and D.S. Lam Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study Br J Ophthalmol 90 7 2006 869 874
15. M. Nicolo, D. Zoli, M. Musolino, and C.E. Traverso Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy Am J Ophthalmol 153 3 2012 474 480
16. J.Y. Shin, S.J. Woo, H.G. Yu, and K.H. Park Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy Retina 31 1 2011 119 126
17. A. Rouvas, P. Stavrakas, and P.G. Theodossiadis et al. Long-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathy Eur J Ophthalmol 22 3 2012 417 422
18. L.A. Yannuzzi, J.S. Slakter, and N.E. Gross et al. Indocyanine green angiography guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study Retina 23 3 2003 288 298
19. F. Cardillo Piccolino, C.M. Eandi, L. Ventre, R.C. Rigault de la Longrais, and F.M. Grignolo Photodynamic therapy for chronic central serous chorioretinopathy Retina 23 6 2003 752 763
20. W.M. Chan, T.Y. Lai, R.Y. Lai, D.T. Liu, and D.S. Lam Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial Ophthalmology 115 10 2008 1756 1765
21. W.M. Chan, T.Y. Lai, R.Y. Lai, E.W. Tang, D.T. Liu, and D.S. Lam Safety-enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study Retina 28 1 2008 85 93
22. F. Senturk, M. Karacorlu, H. Ozdemir, S.A. Karacorlu, and O. Uysal Microperimetric changes after photodynamic therapy for central serous chorioretinopathy Am J Ophthalmol 151 2 2011 303 309
23. K. Fujita, K. Shinoda, and Y. Imamura et al. Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy Am J Ophthalmol 154 3 2012 579 585
24. K. Fujita, M. Yuzawa, and R. Mori Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results Retina 31 4 2011 772 778
25. C. Boni, P. Kloos, and C. Valmaggia New guidelines in the treatment of persistent central serous chorioretinopathy: PDT with half-dose verteporfin Klin Monbl Augenheilkd 229 4 2012 327 330
26. Z.H. Wu, R.Y. Lai, Y.W. Yip, W.M. Chan, D.S. Lam, and T.Y. Lai Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial Retina 31 7 2011 1378 1386
27. R.F. Spaide, H. Koizumi, and M.C. Pozzoni Enhanced depth imaging spectral-domain optical coherence tomography Am J Ophthalmol 146 4 2008 496 500
28. I. Maruko, T. Iida, Y. Sugano, A. Ojima, M. Ogasawara, and R.F. Spaide Subfoveal choroidal thickness after treatment of central serous chorioretinopathy Ophthalmology 117 9 2010 1792 1799
29. Y. Imamura, T. Fujiwara, R. Margolis, and R.F. Spaide Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy Retina 29 10 2009 1469 1473
30. I. Maruko, T. Iida, Y. Sugano, A. Ojima, and T. Sekiryu Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy Retina 31 8 2011 1603 1608
31. A. Pryds, and M. Larsen Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy Acta Ophthalmol 90 8 2012 738 743
32. N.H. Kang, and Y.T. Kim Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy Eye 27 3 2013 387 391
33. R. Uetani, Y. Ito, K. Oiwa, K. Ishikawa, and H. Terasaki Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy Eye 26 5 2012 640 649
34. D.M. de Bruin, D.L. Burnes, and J. Loewenstein et al. In vivo three-dimensional imaging of neovascular age-related macular degeneration using optical frequency domain imaging at 1050 nm Invest Ophthalmol Vis Sci 49 10 2008 4545 4552
35. B. Potsaid, B. Baumann, and D. Huang et al. Ultrahigh speed 1050nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second Opt Express 18 19 2010 20029 20048
36. Y. Yasuno, Y. Hong, and S. Makita et al. In vivo high-contrast imaging of deep posterior eye by 1-micron swept source optical coherence tomography and scattering optical coherence angiography Opt Express 15 10 2007 6121 6139
37. M. Hirata, A. Tsujikawa, and A. Matsumoto et al. Macular choroidal thickness and volume in normal subjects measured by swept-source optical coherence tomography Invest Ophthalmol Vis Sci 52 8 2011 4971 4978
38. P. Jirarattanasopa, S. Ooto, and A. Tsujikawa et al. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy Ophthalmology 119 8 2012 1666 1678
39. S. Kuroda, Y. Ikuno, and Y. Yasuno et al. Choroidal thickness in central serous chorioretinopathy Retina 33 2 2013 302 308
40. T. Iida, S. Kishi, N. Hagimura, and K. Shimizu Persistence and bilateral choroidal vascular abnormalities in central serous chorioretinopathy Retina 19 6 1999 508 512